Zonisamide

Keyphrases

• Antiepileptic Drugs 50%
• Blood Levels 50%
• Epilepsy Syndrome 50%
• Epileptic Rats 50%
• Generalized Epilepsy 50%
• Insolubility 50%
• Localization-related Epilepsy 50%
• Long Half-life 50%
• Low Protein 50%
• Myoclonic Epilepsy 50%
• Parenteral Formulation 50%
• Patients with Epilepsy 50%
• Pharmacokinetics 50%
• Protein Binding 50%
• Safety Profile 50%
• Teratogenicity 50%
• Two-dose 50%
• Zonisamide 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Animal Models of Epilepsy 50%
• Anticonvulsive Agent 50%
• Generalised Epilepsy 50%
• Myoclonus Epilepsy 50%
• Protein Binding 50%
• Syndrome 50%
• Teratogenicity 50%
• Zonisamide 100%